PBH  valuation analysis

Basics
Name: Prestige Consumer Healthcare Inc
Description: Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. (more)
Industry: Medical Distribution
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 04, 2021
Market cap: $2.18B (1023rd)
Sales(TTM): $956.84M (1001st)
Earnings(TTM): $166.21M (625th)

Value
FFER: 0.79 (why)
Actual price: $43.76
FFEThis is Prestige Consumer Healthcare Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $56.39
Quantile: PBH is cheap given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Prestige Consumer Healthcare Inc's earnings increased from -$34.04M to $166.21M in the last year.
Earnings / MarketCap
Prestige Consumer Healthcare Inc
"Medical Distribution" industry
Sales / MarketCap
Prestige Consumer Healthcare Inc
"Medical Distribution" industry
Book / MarketCap
Prestige Consumer Healthcare Inc
"Medical Distribution" industry
Equity / Assets
Prestige Consumer Healthcare Inc
"Medical Distribution" industry